Inova Blog
Partnering news & trends
The Need to Know for Successful Alliance Management in the Life Sciences
We had the pleasure of hosting life science Alliance Management experts Rob Barber, Senior Director...
Biopharma’s Year in Review: 2021’s biggest deals & partnerships
2021 was another record-breaking year in biopharma partnering, both in terms of deal size and activ...
A Behind the Scenes Look at Pierre Fabre’s Private Partnering Event
Necessity is the mother of invention. That saying has proven true throughout all areas of life durin...
Biopharma Partnering - lessons from BD&L Summit
One event I try to make every year is the BD&L Summit for Life Sciences, and this year was...
2020: The Year Pharma Rethinks Partnering
The first few days of a new year seem to encourage a certain type of speculation here on LinkedIn.
Y...
Gene therapy is hot on the partnering agenda
Gene therapy is undoubtedly making a comeback. After early difficulties and failures, there has been...
Collaboration in Pharma – Today’s Business Imperative
It wasn’t that long ago that the pharma giants were fierce competitors. Back then, conversations a...
How pricing is impacting oncology partnerships
A lot is happening in the field of Oncology. Cancer remains a leading cause of death, but innovative...
Building an alliance culture that fosters an open and transparent communication between parties
A few weeks ago, we launched our 7 Best Practices for Building a Successful Alliance Management Func...
From conferences to deal signature: the long road to partnership
It's a long road to partnership in the life sciences. To manage the process effectively, pharma...
Genentech Partnering: Driving Success with Flexible Alliance Management
Partnering in the life sciences isn’t for the faint of heart. It’s time-consuming, subject to su...
Partnering in the Life Sciences: Collaboration vs M&A
There’s a general consensus that partnering and M&A in the life sciences enable access to exte...
Why Partnering Works
There’s no doubt that partnering has a positive impact on pipeline value. Externally sourced asset...
Overcoming the Challenges of Collaboration to be a Partner of Choice
Last week, our guest contributor, Pascal Goursaud, CEO of BACARU and General Secretary of ASAP Franc...
Open Innovation - Not just a catchy phrase, proof from P&G that it really works
Open innovation has become a full-blown buzzword, one that promises improved quality, reduced expend...
A unified Business Development and Partnering system, lessons learned from a Biopharma Leader
We recently finalized the deployment of our Business Development & Licensing product suite at on...
